Sp480

PANEL DISCUSSION

Date
May 7, 2023
Explore related products in the following collection:

Society: AGA

While the immunology of celiac disease is considered well understood, there have been a number of important developments in recent years which improve our understanding of disease triggers, symptom presentation and treatment challenges and may provide insights into other immune mediated diseases. This session is planned as a mixed session with overviews of new concepts in cellular and cytokine manifestations of celiac disease followed by presentation of relevant abstracts.

Tracks

Related Products

Thumbnail for MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
Thumbnail for PLACEHOLDER
PLACEHOLDER
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…